Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-19

Clinical Trial Update: Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi [NA]

View source ↗

Summary

Clinical trial update on ART patients in Malawi comparing daily trimethoprim-sulfamethoxazole vs weekly chloroquine; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)
  • Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: HIV | NA | Status: COMPLETED | Results posted: 2021-05-19